Persistence of Cryoglobulinemic Vasculitis after DAA Induced HCV Cure

Treatment with a direct acting antiviral (DAA) has revolutionized HCV therapy, as more than 95% of patients achieve a sustained virological response (SVR). Cryoglobulinemic vasculitis (CryoVas), however, can persist and recur after the HCV cure. In this systematic review, we include data from 19 stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Danishwar, Mahmood, Jamil, Zahid, Khan, Salman, Nakhla, Michael, Ahmad, Ishtiaq, Ali, Muhammad Ashar, Lau, Daryl T. Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878349/
https://www.ncbi.nlm.nih.gov/pubmed/35207257
http://dx.doi.org/10.3390/jcm11040984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878349/
https://www.ncbi.nlm.nih.gov/pubmed/35207257
http://dx.doi.org/10.3390/jcm11040984

Ejemplares similares